๐ต๏ธ Moleculin Biotech, Inc. ($MBRX)
SEC insider & ownership activity, last 12 months ยท CIK 1659617 ยท every row links its SEC filing
Insiders were quiet over the last 12 months โ no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) ยท 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jun 30, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jun 30, 2026 | filing โ |
| Reg FD disclosure (7.01) | Jun 30, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jun 30, 2026 | filing โ |
| Reg FD disclosure (7.01) | Jun 5, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jun 5, 2026 | filing โ |
| Reg FD disclosure (7.01) | May 29, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | May 29, 2026 | filing โ |
| Reg FD disclosure (7.01) | May 26, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | May 26, 2026 | filing โ |
| Reg FD disclosure (7.01) | May 22, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | May 22, 2026 | filing โ |
| Earnings (2.02) | May 15, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing โ |
| Reg FD disclosure (7.01) | May 13, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing โ |
| Reg FD disclosure (7.01) | May 12, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing โ |
| Reg FD disclosure (7.01) | May 8, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | May 8, 2026 | filing โ |
| Reg FD disclosure (7.01) | Apr 23, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Apr 23, 2026 | filing โ |
| Shareholder vote (5.07) | Apr 15, 2026 | filing โ |
| Reg FD disclosure (7.01) | Mar 23, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing โ |
| Reg FD disclosure (7.01) | Mar 19, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Mar 19, 2026 | filing โ |
| Earnings (2.02) | Mar 19, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Mar 19, 2026 | filing โ |
| Material agreement (1.01) | Feb 19, 2026 | filing โ |